Clinical Trials Directory

Trials / Sponsors / RAPT Therapeutics, Inc.

RAPT Therapeutics, Inc.

Industry · 8 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingPhase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
Ig-E Mediated Food Allergy
Phase 22025-10-22
TerminatedPhase 2 Study to Evaluate RPT193 in Adults With Moderate to Severe T2-high Asthma
Asthma
Phase 22023-07-05
CompletedStudy of RPT193 in Healthy Adult Male Subjects
Healthy Male Subjects
Phase 12023-07-05
TerminatedAn Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis
Atopic Dermatitis
Phase 22022-06-07
TerminatedFLX475 in Combination With Ipilimumab in Advanced Melanoma
Advanced Melanoma
Phase 22021-09-03
CompletedA First-in-Human Study of RPT193 in Healthy Volunteers and Patients With Atopic Dermatitis
Atopic Dermatitis
Phase 12019-08-12
CompletedDose Escalation and Expansion Study of FLX475 Monotherapy and in Combination with Pembrolizumab
Advanced Cancer
Phase 1 / Phase 22018-09-25
TerminatedFirst-in-Human Study of FLX925 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia
Acute Myeloid Leukemia
Phase 12015-04-08